Similar articles

• A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy.

  Lewis RM, Janney RP, Van Buren CT, Kerman RH, Herson J, Kerr NA, Golden DA, Kahan BD. Lewis RM, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):534-9. Transplant Proc. 1988. PMID: 3291291 No abstract available.
• Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.

  Spielberger M, Aigner F, Schmid T, Bösmüller C, Königsrainer A, Margreiter R. Spielberger M, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):169-70. Transplant Proc. 1988. PMID: 3291236 Clinical Trial. No abstract available.
• Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.

  Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA. Hoitsma AJ, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):161-3. Transplant Proc. 1988. PMID: 3291234 No abstract available.
• A prospective study of cyclosporine monitoring in renal transplantation.

  Lindholm A. Lindholm A. Transplant Proc. 1990 Jun;22(3):1260-3. Transplant Proc. 1990. PMID: 2190388 Review. No abstract available.
• The case against the indefinite use of cyclosporine.

  Myers BD, Newton L, Oyer P. Myers BD, et al. Transplant Proc. 1991 Feb;23(1 Pt 1):41-2. Transplant Proc. 1991. PMID: 1990570 Review. No abstract available.